Search results for "030209 endocrinology & metabolism"

showing 10 items of 1146 documents

Sarcopenia and appendicular muscle mass as predictors of impaired fasting glucose/type 2 diabetes in elderly women

2021

Elderly women exhibit a high risk of type 2 diabetes (T2D), but no definitive data exist about the possible role of postmenopausal increases in visceral adiposity, the loss of lean body mass, or decreases in the sum of the lean mass of arms and legs (appendicular skeletal muscle mass (ASMM)). This retrospective, longitudinal study investigated whether body composition (bioelectrical impedance analysis) predicted the development of impaired fasting glucose (IFG) or T2D in a cohort of 159 elderly women (age: 71 ± 5 years, follow-up: 94 months) from southern Italy (Clinical Nutrition and Geriatric Units of the “Mater Domini” University Hospital in Catanzaro, Calabria region, and the “P. Giacco…

endocrine system diseasesappendicular skeletal muscle mass.Type 2 diabetes030204 cardiovascular system & hematologyBody Mass IndexCohort StudiesEating0302 clinical medicineTX341-641Longitudinal StudiesSettore MED/49 - Scienze Tecniche Dietetiche ApplicateSicilyNutrition and DieteticsHand StrengthdiabetesFastingaging; appendicular skeletal muscle mass; body composition; diabetes; nutrition; sarcopenianutritionItalydiabetes; aging; nutrition; body composition; sarcopenia; appendicular skeletal muscle mass.FemaleBioelectrical impedance analysisappendicular skeletal muscle massmedicine.medical_specialtyWaist030209 endocrinology & metabolismClinical nutritionArticlesarcopenia03 medical and health sciencesMuscular DiseasesDiabetes mellitusInternal medicinemedicineHumansMuscle StrengthMuscle SkeletalAgedRetrospective Studiesbody compositionNutrition. Foods and food supplybusiness.industryagingnutritional and metabolic diseasesImpaired fasting glucosemedicine.diseaseGlucoseDiabetes Mellitus Type 2diabeteSarcopeniaLean body massbusinessFood Science
researchProduct

Extracellular Vesicle Encapsulated MicroRNAs in Patients with Type 2 Diabetes Are Affected by Metformin Treatment

2019

Recently, microRNAs (miRNAs) in circulating extracellular vesicles (EVs), have emerged as a source of potential biomarkers for various pathophysiological conditions, including metabolic disorders such as diabetes. Type 2 diabetes mellitus (T2DM), is the most prevalent form of diabetes in the USA, with 30 million diagnosed patients. Identifying miRNA biomarkers that can be used to assess response to glucose lowering treatments would be useful. Using patient plasma samples from a subset of the Danish Metagenomics of the Human Intestinal Tract (MetaHIT) cohort, we characterized miRNAs from whole plasma, plasma-derived EVs, and EV-depleted plasma by small RNA-sequencing to identify T2DM associa…

endocrine system diseaseslcsh:Medicine030209 endocrinology & metabolismType 2 diabetesPharmacologyArticle03 medical and health sciences0302 clinical medicineDiabetes mellitusmicroRNAmedicine030304 developmental biology0303 health sciencesbusiness.industrylcsh:RType 2 Diabetes Mellitusnutritional and metabolic diseasesGeneral MedicineExtracellular vesiclemedicine.diseasePathophysiology3. Good healthMetforminmicroRNAsCohorttype 2 diabetesbusinessextracellular vesiclesmetforminmedicine.drugJournal of Clinical Medicine
researchProduct

Thyroïdites : où en est-on en 2019 ?

2020

Thyroiditis is a frequent and mostly benign disease that can sometimes disrupt the thyroid balance. Their diagnosis, as well as their aetiology, is a necessary step in the management of the patients. Painful thyroiditis includes acute thyroiditis of infectious origin and subacute thyroiditis. The first one can be treated by antibiotics or antifungals depending on the germ found. The second one will be treated with non-steroidal anti-inflammatory drugs or corticosteroids. In cases of Hashimoto's thyroiditis with overt hypothyroidism, replacement therapy with L-thyroxine will be adapted to the TSH level. As amiodarone treatment provides dysthyroidism, the thyroid status should be monitored re…

endocrine systemPediatricsmedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatment[SDV]Life Sciences [q-bio]030209 endocrinology & metabolismContext (language use)AmiodaroneThyroiditis03 medical and health sciences0302 clinical medicineInternal MedicinemedicineSubacute thyroiditisbusiness.industryThyroid diseaseThyroidGastroenterologyImmunotherapymedicine.disease3. Good health[SDV] Life Sciences [q-bio]medicine.anatomical_structure030220 oncology & carcinogenesisEtiologybusinesshormones hormone substitutes and hormone antagonistsmedicine.drug
researchProduct

New antihyperglycaemic agents and cardiovascular disease: let's be optimistic.

2018

Cardiovascular disease (CVD) substantially increases mortality in diabetes mellitus. This narrative review highlights recent research on the putative associations between dipeptyl peptidase 4 inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium glucose co-transporter 2 inhibitors (SGLT-2is) and several cardiovascular risk factors.New antihyperglycaemic agents favourably modulate several CVD risk factors, including fasting and postprandial plasma glucose levels, body weight, blood pressure, lipids, microalbuminuria, nonalcoholic fatty liver disease, serum uric acid, and arterial stiffness. Liraglutide (in LEADER), semaglutide (in SUSTAIN-6), empagliflozin (in EMPA-REG …

endocrine systembusiness.industryMEDLINE030209 endocrinology & metabolismDisease030204 cardiovascular system & hematologyBioinformaticsmedicine.disease03 medical and health sciences0302 clinical medicineCardiovascular DiseasesRisk FactorsDiabetes mellitusMedicineHumansHypoglycemic AgentsNarrative reviewCardiology and Cardiovascular MedicinebusinessRandomized Controlled Trials as TopicCurrent opinion in cardiology
researchProduct

Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease-Methodology and Clinical Applications.

2018

Background Thyroid stimulating hormone receptor antibodies (TSHR-Ab) cause autoimmune hyperthyroidism and are prevalent in patients with related thyroid eye disease (TED). Purpose To provide a historical perspective on TSHR-Ab and to present evidence-based recommendations for clinical contemporary use. Methods The authors review the recent literature pertaining to TSHR-Ab in patients with TED and describe the various immunoassays currently used for detecting TSHR-Ab and their clinical applications. Results We provide a historical summary and description of the various methods used to detect TSHR-Ab, foremost, the functional TSHR-Ab. Increasing experimental and clinical data demonstrate the …

endocrine systemendocrine system diseasesEye disease030209 endocrinology & metabolismAutoimmunitymedicine.disease_causeBioinformaticsAutoimmunity03 medical and health sciences0302 clinical medicineMedicineAnimalsHumansClinical severityReceptorAutoantibodiesbiologybusiness.industryThyroidReceptors ThyrotropinGeneral Medicinemedicine.diseaseClinical diseaseeye diseasesThyroid stimulating hormone receptorGraves OphthalmopathyOphthalmologymedicine.anatomical_structure030220 oncology & carcinogenesisbiology.proteinSurgeryAntibodybusinesshormones hormone substitutes and hormone antagonistsOphthalmic plastic and reconstructive surgery
researchProduct

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective …

2018

Introduction DPP-4 inhibitors (DPP4i) and sulfonylureas are popular second-line therapies for type 2 diabetes (T2D), but there is a paucity of real-world studies comparing their effectiveness in routine clinical practice. Methods This was a multicenter retrospective study on diabetes outpatient clinics comparing the effectiveness of DPP4i versus gliclazide extended release. The primary endpoint was change from baseline in HbA1c. Secondary endpoints were changes in fasting plasma glucose, body weight, and systolic blood pressure. Automated software extracted data from the same clinical electronic chart system at all centers. Propensity score matching (PSM) was used to generate comparable coh…

endocrine systemmedicine.medical_specialtyEpidemiologyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyDatabase03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicinemedicineClinical endpointDatabase; Epidemiology; Pharmacotherapy; Internal Medicine; Endocrinology Diabetes and MetabolismInternal MedicineOutpatient clinicGliclazideOriginal ResearchGlycemicbusiness.industrynutritional and metabolic diseasesDatabase; Epidemiology; PharmacotherapyRetrospective cohort studymedicine.diseasePharmacotherapyMetforminDiabetes and Metabolismbusinessmedicine.drug
researchProduct

A Novel Long-Term Graves’ Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies

2020

<b><i>Introduction:</i></b> A novel long-term murine model for Graves’ disease (GD) using repeated, long-term immunizations with recombinant adenovirus expressing the extracellular A-subunit of the human thyrotropin receptor (Ad-TSHR) was applied to evaluate the functional anti-TSHR-antibody (TSHR-Ab) profile. <b><i>Methods:</i></b> BALB/c mice received 7 immunizations with either 10<sup>10</sup> plaque-forming units of Ad-TSHR or control Ad-GFP. Naïve (nonimmuized native) mice were also studied. Three 3-weekly immunizations were followed by 4-weekly boosts until the 7th immunization. Blocking (TBAb) and stimulating (TSAb) TSHR-Ab …

endocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismGraves' disease030209 endocrinology & metabolismlaw.inventionThyrotropin receptor03 medical and health sciences0302 clinical medicineAnimal modellawInternal medicinemedicineExtracellularmedicine.diagnostic_testbiologybusiness.industrymedicine.diseaseSerum sampleseye diseasesEndocrinology030220 oncology & carcinogenesisImmunoassaybiology.proteinRecombinant DNAAntibodybusinessResearch ArticleEuropean Thyroid Journal
researchProduct

Personality types in individuals with type 1 and type 2 diabetes

2020

Objective The Type A personality, characterized by impatience, strong career ambition and competitiveness, is associated with greater sensitivity to external stress. Type 1 diabetes (T1D) is an auto-immune disease, which is potentially influenced by stress, unlike type 2 diabetes (T2D). The aim of this study was to assess whether individuals with T1D and T2D exhibited significant differences on the Type A personality scale. We also assessed personality in patients with thyroid auto-immune diseases to validate potential links between auto-immune disease and Type A personality. Design and methods The Bortner questionnaire was used to assess Type A personality in 188 patients with T1D, 430 pa…

endocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedia_common.quotation_subject030209 endocrinology & metabolismDiseaseType 2 diabeteslcsh:Diseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicinePersonalitythyroid disease030212 general & internal medicinetype a personalityauto-immunitymedia_commonType 1 diabeteslcsh:RC648-665business.industryResearchThyroid diseaseThyroidnutritional and metabolic diseasesType A and Type B personality theorymedicine.diseasemedicine.anatomical_structurediabetes mellitusbusinessEndocrine Connections
researchProduct

Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.

2010

Objectives To investigate the effects of combined hormone replacement therapy (HRT) and its effective agents on the IGF-1 signaling pathway. Design and methods To examine the effects of HRT on skeletal muscle in vivo, we utilized pre- and post-intervention samples from a randomized double blinded trial with 50–57-year-old women. The intervention included the year-long use of either HRT preparation (2 mg 17β-estradiol, E2; 1 mg norethisterone acetate, NETA, n = 10) or placebo (CO, n = 9). Microarray technology and quantitative PCR (qPCR) were used to study the expression of insulin-like growth factor I (IGF-1) and its splice variants as well as IGF-1 receptor, Akt1, mTOR, FOXO1, FOXO3, atrog…

estradioliTranscription GeneticEndocrinology Diabetes and MetabolismMuscle Fibers SkeletalEstrogen receptorpostmenopausal womenMuscle ProteinsFOXO1Receptor IGF Type 10302 clinical medicineEndocrinologyProtein IsoformsTestosteroneInsulin-Like Growth Factor IReceptorRandomized Controlled Trials as Topic0303 health sciencesEstradiolMyogenesisForkhead Box Protein O1TOR Serine-Threonine KinasesEstrogen Replacement TherapyForkhead Box Protein O3Forkhead Transcription FactorsMiddle Agedmedicine.anatomical_structureReceptors EstrogenReceptors AndrogenFemalemedicine.medical_specialtynorethisterone acetate030209 endocrinology & metabolismBiologypostmenopausaalinen nainen03 medical and health sciencesInternal medicinemedicineHumansnoretisteroniasetaattiluurankolihasskeletal muscleMuscle SkeletalProtein kinase BPI3K/AKT/mTOR pathway030304 developmental biologyhormonikorvaushoitoSKP Cullin F-Box Protein LigasesSkeletal muscleAndrogen receptorNorethindrone AcetateEndocrinologyHormone replacement therapyIGF-1 signalointiNorethindroneIGF-1 signalingProto-Oncogene Proteins c-aktGrowth hormoneIGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
researchProduct

Aging of the musculoskeletal system: How the loss of estrogen impacts muscle strength.

2019

Skeletal muscle weakness occurs with aging and in females this is compounded by the loss of estrogen with ovarian failure. Estrogen deficiency mediates decrements in muscle strength from both inadequate preservation of skeletal muscle mass and decrements in the quality of the remaining skeletal muscle. Processes and components of skeletal muscle that are affected by estrogens are beginning to be identified. This review focuses on mechanisms that contribute to the loss of muscle force generation when estrogen is low in females, and conversely the maintenance of strength by estrogen. Evidence is accumulating that estrogen deficiency induces apoptosis in skeletal muscle contributing to loss of…

estrogeenit0301 basic medicinemedicine.medical_specialtyAgingProteasome Endopeptidase ComplexHistologyPhysiologymedicine.drug_classEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismApoptosisArticle03 medical and health sciences0302 clinical medicineInternal medicineestrogenmedicineHumansMuscle Strengthskeletal muscleta315Muscle SkeletalMuscle forcebusiness.industryagingOvarian failureUbiquitinationSkeletal muscleta3141Estrogensmedicine.diseaseGenerating capacityikääntyminen030104 developmental biologymedicine.anatomical_structureEndocrinologyEstrogenSarcopeniaMuscle strengthEstrogenic EffectsFemalestrengthbusinesshormones hormone substitutes and hormone antagonistslihasvoimaBone
researchProduct